UK: Innovating Life Sciences In The Fourth Industrial Revolution: Embrace, Build, Grow

Last Updated: 26 February 2018
Article by Mark Steedman

The term 'revolution' is often used to define a popular uprising that can lead to dramatic political changes. A dictator is overthrown, a new government is formed, a constitution is changed or replaced, and immeasurable impact on the country or even the world can occur. However, other types of revolutions also happen. Some of the most commonly known are industrial revolutions, which refer to breakthroughs in technology that change how industries function. We are now seeing the beginnings of a fourth industrial revolution – a fusing of technologies blurring the boundaries between the physical, digital and biological worlds.1 This blog highlights the issues that Deloitte believe will cause the most disruption for life sciences in 2018 as we embark on this fourth industrial revolution.

The history of industrial revolutions and the impact on life sciences trends in 2018

Over the course of history, industry has benefited from qualitative advancements that have become so ingrained in a certain time period and have had such an overwhelming impact that they have become known as 'revolutions':

  • The first industrial revolution began in the late-1780s, with the emergence of mechanisation and mass production, with industry replacing agriculture as the foundations of the economic structure of society. The mass extraction of coal and the development of the steam engine created a new form of energy, leading to the adoption of new manufacturing processes in factories across the world2
  • The second industrial revolution in the late 19th and early 20th centuries, known as the technological revolution, was defined by several technological breakthroughs that led to the emergence of new forms of energy, principally electricity, oil and gas. The invention of the combustion engine, printing presses, the telephone and new processes for making steel resulted in heavily populated cities full of skyscrapers, railroads crisscrossing continents, and widespread use of heavy machinery3
  • The third industrial revolution marked the shift from mechanical and analogue electronic technology to the digital electronics we use today, with digital computers becoming commonplace, and the appearance of the Internet connecting the world. Termed the digital revolution, it began in the 1980s and laid the foundation for  fundamental economic change, as new communication technologies converged with new energy regimes, mainly, renewable electricity4
  • The fourth revolution is unfolding at pace, underpinned by digitalisation, and driven by interconnection via the Internet and computing devices embedded in everyday objects, enabling them to send and receive data.5 

For the life sciences industry, the fourth industrial revolution is characterised by emerging technologies utilising artificial and augmented intelligence, robotics, the Internet of Things, 3-D printing, and nanotechnology, combined with unprecedented data processing power, storage capacity and access to knowledge that will lead to transformative scientific achievements. Deloitte's recent report 2018 Global life sciences outlook: Innovating life sciences in the fourth industrial revolution: Embrace, build, grow provides a high level view of what to expect in the next year and beyond, as many of these technologies begin to impact the life sciences industry.

The report begins with an economic overview of the industry, including growth trends in the overall pharmaceutical market, and specific therapeutic trends for orphan drugs, biologics and biosimilars, generics, medical technology (medtech) and personalised medicine (see Figure 1). Further analysis also looks at M&A investment trends in the life sciences and medtech industries.

Figure 1: Growth trends in the life sciences industry

Embracing technology and geopolitical change

Advances in science and technology meant that in 2017 the FDA sanctioned 46 novel medicines, the highest number of drug approvals in 21 years.6 We expect these types of breakthroughs to continue in 2018, although these will be coupled with increasing concerns about R&D costs and the affordability of the resulting treatment, as discussed in our report  A new future for R&D? Measuring the return from pharmaceutical innovation 2017. Many new drugs will be accompanied by companion diagnostics and rely on advances in technologies such as 3D printing, gene therapy and artificial intelligence, while cognitive computing will be used to improve patient outcomes. 

At the same time, cloud computing will be adopted at scale, due to the speed, flexibility and security it provides. These technologies will also help accelerate R&D processes and optimise supply chains. While the potential for blockchain, one of life sciences' much discussed technologies, remains to be seen, many pharma companies are starting to explore the technology through pilots.

In addition, if life sciences companies are to survive, they will also need to embrace geopolitical change. Tax reforms and changes in regulation will create incentives and disincentives across the life sciences sector and impact future investments. Although there is still uncertainty as to how regulators will respond to the impacts of digital technologies, more direct engagement and collaboration between companies and key regulatory bodies will be required to clarify compliance requirements and avoid significant legal and financial ramifications of non-compliance.

Build and grow new horizons

New rules are redefining how life sciences companies build their organisations and navigate the future of work. Talent will be a differentiator in a skills-based economy, and the combination of machine intelligence with human skills and insight will allow companies to thrive.

With the potential all of new technologies to transform services, the demand for data, analytical and artificial intelligence talent is increasing and presents significant challenges for an industry where such skills and talent are in short supply. As well as improving processes, new talent will be needed to deal with the scale and complexity of cyber threats, which are expected to increase to the extent that organisations will elevate cybersecurity to a constant, critical priority.

A new culture of courage will also be required to help counter uncertainty, and companies will need to be ethical and proactive in minimising risk, particularly around cybersecurity. This will also require maximising the value of data by building data integrity into working environments and building patient trust and centricity to create a holistic ecosystem across the life sciences value chain.

Partnerships will play a large role in helping the industry grow in 2018. Strategic scientific, clinical and regulatory alliances, particularly with new entrants to the industry, will enable companies to acquire new knowledge about technologies, processes, products and business models. Other growth opportunities will be found in new operating models, whether R&D, supply chain or commercial processes.

What's next: Actions for 2018

With the arrival of the fourth industrial revolution, the life sciences industry is embarking on a transformative technology journey. The following actions should allow stakeholders to address uncertainties and utilise the strategies needed to survive and thrive in 2018 (see Figure 2):

Figure 2: Actions for 2018 and beyond

Footnotes

1. Schwab K. The fourth industrial revolution: what it means, how to respond. World Economic Forum, 2016. See also: https://www.weforum.org/agenda/2016/01/the-fourth-industrial-revolution-what-it-means-and-how-to-respond/

2. The third industrial revolution. The Economist, 2012. See also: http://www.economist.com/node/21553017

3. Muntone S. Second Industrial Revolution. Education.com, 2012. See also: https://web.archive.org/web/20131022224325/http://www.education.com/study-help/article/us-history-glided-age-technological-revolution/

4. Digital revolution. Technopedia. See also: https://www.techopedia.com/definition/23371/digital-revolution

5. The Fourth Industrial Revolution is here – are you ready? Deloitte Insights, 2018. See also: https://www2.deloitte.com/insights/us/en/deloitte-review/issue-22/industry-4-0-technology-manufacturing-revolution.html?id=us:2em:3na:4di4364:5eng:6di:021518:4ireadiness&sfid=0031400002vBiuaAAC

6. Hirschler B. New drug approvals hit 21-year high in 2017. Reuters, 2 January 2018. See also: https://www.reuters.com/article/us-pharmaceuticals-approvals/new-drug-approvals-hit-21-year-high-in-2017-idUSKBN1ER0P7

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions